175 related articles for article (PubMed ID: 30327411)
1. G protein subtype-specific signaling bias in a series of CCR5 chemokine analogs.
Lorenzen E; Ceraudo E; Berchiche YA; Rico CA; Fürstenberg A; Sakmar TP; Huber T
Sci Signal; 2018 Oct; 11(552):. PubMed ID: 30327411
[TBL] [Abstract][Full Text] [Related]
2. High-Affinity Binding of Chemokine Analogs that Display Ligand Bias at the HIV-1 Coreceptor CCR5.
Rico CA; Berchiche YA; Horioka M; Peeler JC; Lorenzen E; Tian H; Kazmi MA; Fürstenberg A; Gaertner H; Hartley O; Sakmar TP; Huber T
Biophys J; 2019 Sep; 117(5):903-919. PubMed ID: 31421836
[TBL] [Abstract][Full Text] [Related]
3. Purinergic Receptors Crosstalk with CCR5 to Amplify Ca
Horioka M; Ceraudo E; Lorenzen E; Sakmar TP; Huber T
Cell Mol Neurobiol; 2021 Jul; 41(5):1085-1101. PubMed ID: 33216235
[TBL] [Abstract][Full Text] [Related]
4. Arrestin Recruitment to C-C Chemokine Receptor 5: Potent C-C Chemokine Ligand 5 Analogs Reveal Differences in Dependence on Receptor Phosphorylation and Isoform-Specific Recruitment Bias.
Martins E; Brodier H; Rossitto-Borlat I; Ilgaz I; Villard M; Hartley O
Mol Pharmacol; 2020 Nov; 98(5):599-611. PubMed ID: 32943494
[TBL] [Abstract][Full Text] [Related]
5. Molecular anatomy of CCR5 engagement by physiologic and viral chemokines and HIV-1 envelope glycoproteins: differences in primary structural requirements for RANTES, MIP-1 alpha, and vMIP-II Binding.
Navenot JM; Wang ZX; Trent JO; Murray JL; Hu QX; DeLeeuw L; Moore PS; Chang Y; Peiper SC
J Mol Biol; 2001 Nov; 313(5):1181-93. PubMed ID: 11700073
[TBL] [Abstract][Full Text] [Related]
6. Chemokine receptor CCR5 functionally couples to inhibitory G proteins and undergoes desensitization.
Zhao J; Ma L; Wu YL; Wang P; Hu W; Pei G
J Cell Biochem; 1998 Oct; 71(1):36-45. PubMed ID: 9736452
[TBL] [Abstract][Full Text] [Related]
7. Analysis of second messenger pathways stimulated by different chemokines acting at the chemokine receptor CCR5.
Leach K; Charlton SJ; Strange PG
Biochem Pharmacol; 2007 Sep; 74(6):881-90. PubMed ID: 17645873
[TBL] [Abstract][Full Text] [Related]
8. In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression.
Scarlatti G; Tresoldi E; Björndal A; Fredriksson R; Colognesi C; Deng HK; Malnati MS; Plebani A; Siccardi AG; Littman DR; Fenyö EM; Lusso P
Nat Med; 1997 Nov; 3(11):1259-65. PubMed ID: 9359702
[TBL] [Abstract][Full Text] [Related]
9. Highly potent, fully recombinant anti-HIV chemokines: reengineering a low-cost microbicide.
Gaertner H; Cerini F; Escola JM; Kuenzi G; Melotti A; Offord R; Rossitto-Borlat I; Nedellec R; Salkowitz J; Gorochov G; Mosier D; Hartley O
Proc Natl Acad Sci U S A; 2008 Nov; 105(46):17706-11. PubMed ID: 19004761
[TBL] [Abstract][Full Text] [Related]
10. Targeting spare CC chemokine receptor 5 (CCR5) as a principle to inhibit HIV-1 entry.
Jin J; Colin P; Staropoli I; Lima-Fernandes E; Ferret C; Demir A; Rogée S; Hartley O; Randriamampita C; Scott MG; Marullo S; Sauvonnet N; Arenzana-Seisdedos F; Lagane B; Brelot A
J Biol Chem; 2014 Jul; 289(27):19042-52. PubMed ID: 24855645
[TBL] [Abstract][Full Text] [Related]
11. Aminooxypentane addition to the chemokine macrophage inflammatory protein-1alpha P increases receptor affinities and HIV inhibition.
Townson JR; Graham GJ; Landau NR; Rasala B; Nibbs RJ
J Biol Chem; 2000 Dec; 275(50):39254-61. PubMed ID: 11005816
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological characterization of the chemokine receptor, CCR5.
Mueller A; Mahmoud NG; Goedecke MC; McKeating JA; Strange PG
Br J Pharmacol; 2002 Feb; 135(4):1033-43. PubMed ID: 11861332
[TBL] [Abstract][Full Text] [Related]
13. Effect of CCR5 receptor antagonists on endocytosis of the human CCR5 receptor in CHO-K1 cells.
Longden J; Cooke EL; Hill SJ
Br J Pharmacol; 2008 Apr; 153(7):1513-27. PubMed ID: 18223665
[TBL] [Abstract][Full Text] [Related]
14. Potent Anti-HIV Chemokine Analogs Direct Post-Endocytic Sorting of CCR5.
Bönsch C; Munteanu M; Rossitto-Borlat I; Fürstenberg A; Hartley O
PLoS One; 2015; 10(4):e0125396. PubMed ID: 25923671
[TBL] [Abstract][Full Text] [Related]
15. The GHS-R blocker D-[Lys3] GHRP-6 serves as CCR5 chemokine receptor antagonist.
Patel K; Dixit VD; Lee JH; Kim JW; Schaffer EM; Nguyen D; Taub DD
Int J Med Sci; 2012; 9(1):51-8. PubMed ID: 22211090
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of HIV-1 replication by GB virus C infection through increases in RANTES, MIP-1alpha, MIP-1beta, and SDF-1.
Xiang J; George SL; Wünschmann S; Chang Q; Klinzman D; Stapleton JT
Lancet; 2004 Jun; 363(9426):2040-6. PubMed ID: 15207954
[TBL] [Abstract][Full Text] [Related]
17. Structural basis for chemokine recognition and receptor activation of chemokine receptor CCR5.
Zhang H; Chen K; Tan Q; Shao Q; Han S; Zhang C; Yi C; Chu X; Zhu Y; Xu Y; Zhao Q; Wu B
Nat Commun; 2021 Jul; 12(1):4151. PubMed ID: 34230484
[TBL] [Abstract][Full Text] [Related]
18. The CXC chemokine receptor encoded by herpesvirus saimiri, ECRF3, shows ligand-regulated signaling through Gi, Gq, and G12/13 proteins but constitutive signaling only through Gi and G12/13 proteins.
Rosenkilde MM; McLean KA; Holst PJ; Schwartz TW
J Biol Chem; 2004 Jul; 279(31):32524-33. PubMed ID: 15155729
[TBL] [Abstract][Full Text] [Related]
19. Involvement of both the V2 and V3 regions of the CCR5-tropic human immunodeficiency virus type 1 envelope in reduced sensitivity to macrophage inflammatory protein 1alpha.
Maeda Y; Foda M; Matsushita S; Harada S
J Virol; 2000 Feb; 74(4):1787-93. PubMed ID: 10644351
[TBL] [Abstract][Full Text] [Related]
20. Biased signaling at chemokine receptors.
Corbisier J; Galès C; Huszagh A; Parmentier M; Springael JY
J Biol Chem; 2015 Apr; 290(15):9542-54. PubMed ID: 25614627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]